Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1CNS 1

Conditions

Gliosarcoma 22Glioblastoma 22Brain Neoplasms 16Glioma 10Astrocytoma 9Oligodendroglioma 8Central Nervous System Neoplasms 7Squamous Cell Carcinoma of Head and Neck 3Carcinoma, Non-Small-Cell Lung 3Sarcoma 2Salivary Gland Neoplasms 2Rectal Neoplasms 2Pancreatic Neoplasms 2Osteosarcoma 2Medulloblastoma 2Gastrointestinal Stromal Tumors 2Esthesioneuroblastoma, Olfactory 2Esophageal Neoplasms 2Ependymoma 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Anus Neoplasms 2Wilms Tumor 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Tongue Neoplasms 1Stomach Neoplasms 1Spinal Cord Neoplasms 1Small Cell Lung Carcinoma 1

Interventions

Oncolytic Virotherapy 2repotrectinib 1pembrolizumab 1pamiparib 1interferon gamma-1b 1cixutumumab 1Vincristine 1Thiotepa 1Temozolomide 1Radiation 1Peripheral Blood Stem Cell Transplantation 1ONC206 1Melphalan 1Interferon-gamma 1Immunotherapy 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Erlotinib Hydrochloride 1Doxorubicin 1Cyclophosphamide 1Busulfan 1Bone Marrow Transplantation 1Antibodies, Monoclonal 1Amifostine 1Afatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroectodermal Tumors × Erlotinib Hydrochloride × Sarcoma × Clear all
NCT02689336 2019-09-09

Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors

Washington University School of Medicine

Phase 2 Withdrawn
CNSGenitourinarySarcoma

Ependymoma, Glioma, Medulloblastoma, Wilms Tumor, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Neuroectodermal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡